|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
0.690 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -0.456% | -14.378% | 3.025% | 3.696% | -19.656% |
| ROAE (%) | -1.178% | -29.412% | 4.767% | 5.037% | -24.898% |
| Return on Capital Employed (%) | -0.727% | -19.931% | 3.473% | 4.466% | -26.704% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 69.638% | 68.200% | 74.394% | 77.690% | 79.492% |
| EBITDA Margin (%) | 5.027% | -86.117% | 27.389% | 37.197% | -78.626% |
| Pre-tax Profit Margin (%) | -8.667% | -97.322% | 14.768% | 31.078% | -85.450% |
| Net Profit Margin (%) | -2.903% | -87.792% | 12.655% | 19.210% | -95.371% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.511 X | 2.586 X | 3.094 X | 2.621 X | 2.789 X |
| Quick Ratio (X) | 1.375 X | 2.347 X | 2.808 X | 2.418 X | 2.608 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 55.467% | 53.546% | 36.877% | 23.729% | 20.914% |
| Total Debt / Total Assets (%) | 10.553% | 10.285% | 7.460% | 5.789% | 0.151% |
| Net Debt / Total Assets (%) | -22.204% | -21.253% | -31.741% | -29.508% | -40.554% |
| Total Debt / Shareholders' Funds (%) | 27.467% | 26.360% | 13.054% | 8.216% | 0.197% |
| Long Term Debt / Shareholders' Funds (%) | 21.103% | 18.884% | 10.577% | 3.935% | 0.155% |
| Net Debt / Shareholders' Funds (%) | -57.789% | -54.469% | -55.540% | -41.881% | -53.069% |
| Net Cash / (Debt) ($) | 2.561B | 2.580B | 4.601B | 3.849B | 5.098B |
| Net Cash / (Debt) per share ($) | 0.275 | 0.277 | 0.493 | 0.407 | 0.539 |
| Total Debt / Capital Employed (%) | 16.388% | 12.997% | 9.016% | 7.123% | 0.184% |
| Interest Coverage Ratio (X) | 0.401 X | N/A | 5.074 X | 94.202 X | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 376.060 Day | 347.840 Day | 262.285 Day | 300.578 Day | 219.077 Day |
| Receivables Turnover (Day) | 90.249 Day | 108.881 Day | 64.814 Day | 50.510 Day | 48.608 Day |
| Payables Turnover (Day) | 41.825 Day | 27.167 Day | 12.482 Day | 12.732 Day | 6.506 Day |
| Remarks: | Real time quote last updated: 29/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -33,424,000 |
| %Change | -32.673% |
| EPS / (LPS) | RMB -0.004 |
| NBV Per Share (¥) | RMB 0.474 |